Grand Rounds

Mass General Cancer Center Grand Rounds is a CME accredited weekly seminar series. Cutting edge topics, case studies and conference highlights will be presented.

Location: Simches Research Center, Room 3110
Start time: 12:00 PM

The Massachusetts General Hospital Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. 

Grand Rounds offers CME credit, and is structured as a 45 minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.

PLEASE NOTE: Mass General Cancer Center Grand Rounds are open only to MGH Staff and Faculty.

Calendar of Events 2014
ASH Update
January 9, 2014

Eyal Attar, MD
Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center

Jeffrey Barnes, MD, PhD
Instructor in Medicine
Massachusetts General Hospital Cancer Center

Yi-Bin Chen, MD
Massachusetts General Hospital Cancer Center

Annemarie Fogerty, MD
Instructor in Medicine
Massachusetts General Hospital Cancer Center

Andrew Yee, MD
Instructor in Medicine
Massachusetts General Hospital Cancer Center


 

Cancer Immunotherapies Based on Overcoming Resistance Mechanisms in the Tumor Microenvironment
January 16, 2014

Thomas Gajewski, MD, PhD
The University of Chicago Medicine


 

Good Communication is Not Magic: An Empirical Approach to Talking with Seriously Ill Patients
January 30, 2014

James Tulsky, MD
Professor of Medicine and Nursing
Chief, Duke Palliative Care
Duke University School of Medicine


 

Sarcoma Therapeutics 2014: Doxorubicin for Everyone vs. Precision Medicine
February 6, 2014
Robert Maki, MD, PhD
Mount Sinai Chief of Pediatric Hematology/Oncology
Medical Director, Sarcoma Cancer Program
The Tisch Cancer Institute


 

MDS, Transplantation and the Older Patient
February 13, 2014
Joachim H. Deeg, MD
Professor of Medicine, Division of Medical Oncology
University of Washington School of Medicine


 

Recombinant Immunotoxins: From Conception to Clinical Reality in Mesothelioma and Leukemia
February 27, 2014
Ira Pastan, MD
Head, Molecular Biology Section
Laboratory Co-Chief
Center for Cancer Research
National Cancer Institute


 

Disorders of Chromatin in Hematological Malignancy
March 6, 2014
Johnathan Licht, MD
Chief, Division of Medicine-Hematology/Oncology
Johanna Dobe Professor of Hematology/Oncology
Associate Director for Clinical Sciences Research
Robert H. Lurie Comprehensive Cancer Center Feinberg School of Medicine


 

Clinical Pathologic Conference
March 13, 2014
Speakers TBD


 

Personalizing Treatment for Neuroblastoma: Biologic and Risk-Directed Therapy
March 20, 2014
Katherine K. Matthay, MD
Mildred V. Strouss Professor of Translational Oncology
Director, Pediatric Hematology-Oncology
UCSF School of Medicine and UCSF Benioff Children's Hospital


 

Breast Cancer Intra- and Inter-Tumor Genetic Heterogeneity
March 27, 2014
Jorge Reis-Filho, MD
Department of Pathology
Memorial Sloan-Kettering Cancer Center


 

Glioblastoma Initiating/Stem Cells: Therapeutic Implications
April 3, 2014
Howard Fine, MD
Anne Murnick Cogan & David H. Cogan Professor of Oncology
Director, Division of Hematology & Medical Oncology
Director, NYU Brain Tumor Center
Deputy Director, NYU Cancer Institute
Director, Bellevue Hospital Cancer Center
The New York University (NYU) Langone Medical Center
NYU Cancer Institute


 

NSCLC 2014
May 1, 2014
Thomas J. Lynch, MD
Richard Sackler and Jonathan Sackler Professor of Medicine (Medical Oncology)
Director, Yale Cancer Center
Physician-in-Chief, Smilow Cancer Hospital at Yale-New Haven


 

Clinical Pathologic Conference:
A Patient with Thymoma, Recurrent Infections, Diarrhea, and Anemia
May 8, 2014
Panos Fidias, MD
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital Cancer Center
 
Aidan A. Long, MD
Associate Professor of Medicine, Harvard Medical School
Clinical Director and Training Program Director
Allergy and Clinical Immunology, Massachusetts General Hospital

Lawrence R. Zukerberg, MD
Associate Professor of Pathology
Associate Pathologist
Massachusetts General Hospital Cancer Center
Harvard Medical School


 

Basic Biology of the PD-1 Pathway
May 15, 2014
Arlene H. Sharpe, MD, PhD
Professor, Department of Microbiology and Immunobiology, Harvard Medical School
Co-Director, HITI, Harvard Medical School
Vice Chair for Education, Pathology, Harvard Medical School

 


Calendar of Events 2013

ASCO Update
October 3, 2013

Dejan Juric, MD
Director of Translational Research at Termeer Center for Targeted Therapies
Massachusetts General HospitalJason Faris, MD
GI Cancer Program
Massachusetts General Hospital Cancer Center

Philip Saylor, MD
Assistant Physician, Internal Medicine, Hematology-Oncology
Massachusetts General Hospital
Associate Professor, Department of Medicine
Harvard Medical School

Justin Gainor, MD
Assistant in Medicine
Instructor, Harvard Medical School
Massachusetts General Hospital


Use of Databases to Address Everyday Questions in Management of AML
October 10, 2013

Elihu Estey, MD
Professor of Medicine, Division of Hematology
University of Washington School of Medicine
Member, Fred Hutchinson Cancer Research Center


Clinical Pathologic Conference
October 17, 2013

Mihir Kamdar, MD
Director, Cancer Pain Clinic
Palliative Care and Anesthesia Pain Medicine
Massachusetts General Hospital

Kathleen Doyle, MD
Palliative Care Physician
Massachusetts General Hospital

Efren Flores, MD
Director, Nantucket Cottage Hospital Imaging
Massachusetts General Hospital

Guy Maytal, MD
Associate Director of Ambulatory Psychiatry
Director, Primary Care Psychiatry
Director, Urgent Care Psychiatry
Massachusetts General Hospital

Mari Mino-Kenudson, MD
Associate Pathologist
Massachusetts General Hospital

Todd Rinehart, LICSW, ACHP-SW
Clinical Social Worker
Palliative Care
Massachusetts General Hospital

Lecia V. Sequist, MD, MPH
Thoracic Oncology Center
Massachusetts General Hospital Cancer Center 


Human Papillomavirus and Head and Neck Cancers
October 24, 2013

Maura Gillison, MD, PhD
Professor and Jeg Coughlin Chair of Cancer Research
The Ohio State University Comprehensive Cancer Center


Oncogenic KRAS Reprograms Pancreatic Cancer Metabolism to Support Growth
October 31, 2013

Alec Kimmelman, MD, PhD
Assistant Professor, Radiation Oncology
Harvard Medical School
Assistant Professor, Radiation Oncology
Dana-Farber Cancer Institute


Update on Local Treatment of Breast Cancer: The View from Across Town
November 7, 2013

Jay R. Harris, MD
Professor of Radiation Oncology
Harvard Medical School
Chair, Department of Radiation Oncology
Dana-Farber Cancer Institute
Brigham and Women’s Hospital


Taking the Next Step in Metastatic RCC Therapeutics
November 21, 2013

Brian Rini, MD, FACP
Professor of Medicine, Lerner College of Medicine
Department of Solid Tumor Oncology
Cleveland Clinic Taussig Cancer Institute


A Mutation-Driven View of the Cancer Genome
December 5, 2013

Gordon Mills, MD, PhD
Co-Director, Institute for Personalized Cancer Therapy (IPCT)
Chairman & Professor, Department of Systems Biology
Weiss Distinguished University Chair in Cancer Medicine
University of Texas MD Anderson Cancer Center


Aspirin for the Prevention of Colorectal Cancer
December 12, 2013

Andrew Chan, MD
Associate Physician
Massachusetts General Hospital Cancer Center
Associate Professor of Medicine
Harvard Medical School


 

Oncogene Addiction, Drug Resistance and Pathway Overdose in BRAF Mutated Melanoma
December 19, 2013

Martin McMahon, MD
Efim Guzik Distinguished Professor of Cancer Biology
Helen Diller Family Comprehensive Cancer Center

 


 


 

patient

Among the best in the nation for cancer care

U.S. News & World Report ranks the Mass General Cancer Center in the top 10 among U.S. hospitals.

patient

Learn about targeted therapy clinical trials

Visit TargetedCancerCare.org for more information on the latest genomic research, cancer treatments and clinical trials.

Support the Cancer Center

Your gift of any amount will help us in our mission to advance knowledge and to rapidly translate discovery into exceptional cancer care. Learn more about making a gift, including tribute giving and other ways to get involved.